BECTON, DICKINSON AND COMPANY Finite-Lived Intangible Assets, Net
BECTON, DICKINSON AND COMPANY (BDX) had Finite-Lived Intangible Assets, Net of $8.02 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Assets, Net $8.02B.
- 2026-03-31: Finite-Lived Intangible Assets, Net $8.35B.
- 2025-12-31: Finite-Lived Intangible Assets, Net $9.01B.
- 2025-09-30: Finite-Lived Intangible Assets, Net $9.23B; Finite-Lived Intangible Assets, Net as first filed $9.39B.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $8.02B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.35B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $9.01B 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $9.23B 10-Q · filed 2026-08-06 | $9.39B 10-K · filed 2025-11-25 |
| 2025-06-30 | $9.77B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $10.12B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $10.47B 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $10.87B 10-K · filed 2025-11-25 | |
| 2024-06-30 | $9.86B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $10.21B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $10.57B 10-Q · filed 2024-02-01 | |
| 2023-09-30 | $10.90B 10-K · filed 2024-11-27 | |
| 2023-06-30 | $11.27B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $11.63B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $11.94B 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $12.26B 10-K · filed 2023-11-21 | |
| 2022-06-30 | $11.84B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $12.22B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $12.56B 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $12.73B 10-K · filed 2022-11-22 | $12.74B 10-K · filed 2021-11-24 |
| 2020-09-30 | $13.77B 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |